# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 61-70 of 4047 results.
Lyon Granulomatous Hepatitis Study
Status: Recruiting
Last Changed: Jul 07, 2020
First Received: Jul 07, 2020
Disease(s): Patient Diagnosed or Treated for Granulomatous Hepatitis Followed in the Internal Medicine (and or) Hepato-gastroenterology Departments
Intervention(s): Evaluation of epithelioid and gigantocellular granulomas within the hepatic parenchyma by histopathology approach.
Locations: : Hôpital de la Croix Rousse / GHN / service de médecine interne, Lyon, France
Hôpital Edouard Herriot / service de médecine interne, Lyon, France
Hôpital Lyon Sud / service de médecine interne, Pierre Bénite, France
Study for Consolidation Period of Chronic Hepatitis B
Status: Completed
Last Changed: Apr 19, 2018
First Received: Nov 22, 2012
Disease(s): Hepatitis B
Locations: Chun-Hsiang Wang, Tainan, Taiwan
Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss
Status: Unknown status
Last Changed: May 15, 2012
First Received: May 15, 2012
Disease(s): Hepatitis B
Intervention(s): Entecavir, Peginterferon alfa-2a
Locations: The Third Affliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Study of Oral Treatments for Hepatitis C
Status: Active, not recruiting
Last Changed: Nov 24, 2020
First Received: Jun 01, 2016
Disease(s): Chronic Hepatitis C
Intervention(s): sofosbuvir/ledipasvir, ombitasvir/paritaprevir/ritonavir (Phase 1 only), elbasvir/grazoprevir, Dasabuvir, Ribavirin
Locations: Liver Wellness Center, Little Rock, Arkansas, United States
Stanford University, Palo Alto, California, United States
UCSD Medical Center, San Diego, California, United States
UCSF/Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States
Univ of California, San Francisco, San Francisco, California, United States
... and 34 other locations.
Australian Trial in Acute Hepatitis C
Status: Completed
Last Changed: Apr 15, 2011
First Received: Sep 19, 2005
Disease(s): Hepatitis C
Intervention(s): Pegylated Interferon alfa 2a, Ribavirin (HIV conifected patients only)
Locations: Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
407 Doctors, Darlinghurst, New South Wales, Australia
Holdsworth House GP Practice, Darlinghurst, New South Wales, Australia
Kirketon Road Centre, Darlinghurst, New South Wales, Australia
St Vincent's Hospital, Darlinghurst, New South Wales, Australia
... and 14 other locations.
The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
Status: Completed
Last Changed: Dec 15, 2016
First Received: Feb 14, 2014
Disease(s): Hepatitis C
Intervention(s): Peginterferon lambda
Locations: The Military 108 Hospital, Hanoi, Vietnam
The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Status: Completed
Last Changed: Aug 01, 2016
First Received: Sep 25, 2013
Disease(s): Hepatitis A
Intervention(s): Attenuated HAV Vaccine, H2 Strain, Attenuated HAV Vaccine, L-A-1 Strain, Inactivated HAV Vaccine, Lu8 Strain, Inactivated HAV Vaccine, TZ84 Strain
Locations: Institute of Medical Biology -Chinese Academy of Medical Sciences, Kunming, Yunnan, China
Status: Completed
Last Changed: Aug 19, 2016
First Received: Aug 09, 2016
Disease(s): Acute Hepatitis
Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Status: Active, not recruiting
Last Changed: Nov 09, 2020
First Received: Dec 20, 2010
Disease(s): Hepatitis B
Locations: University of California San Francisco Medical Center, San Francisco, California, United States
Johns Hopkins University, Baltimore, Maryland, United States
University of Minnesota, Minneapolis, Minnesota, United States
Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States
University of Texas Southwestern, Dallas, Texas, United States
... and 3 other locations.
Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genotype 4
Status: Unknown status
Last Changed: Oct 10, 2017
First Received: May 13, 2016
Disease(s): Hepatitis C
Intervention(s): Daclatasvir 60 MG Oral Tablet [Daklinza], Sofosbuvir 400 MG Oral Tablet [Sovaldi], Ribavirin Oral Product